Emergent BioSolutions EBS
NYSE EBS
$6.24 +0.01 (+0.16%)
As of: Oct 23, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) (2010 - 2026)

Updated

Emergent BioSolutions (EBS) posted Property, Plant & Equipment (Net) of $178 million for Q2 2026, down 17.6% from $216.1 million a year earlier and down 10.7% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

At the end of FY2025, Emergent BioSolutions' Property, Plant & Equipment (Net) came in at $205.4 million, down 24.1% from FY2024.

  • Annual Property, Plant & Equipment (Net) has declined for three consecutive years, with a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
  • In prior years, Emergent BioSolutions' Property, Plant & Equipment (Net) was $270.6 million in FY2024 (-29.3%), $382.8 million in FY2023 (-53.2%), $817.6 million in FY2022 (+2.2%) and $800.1 million in FY2021 (+24.2%).
  • The Q2 2026 figure stands as the lowest quarterly Property, Plant & Equipment (Net) since Q2 2011.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has declined in each of the last 14 quarters, with an average decline of 25.8% over the last eight quarters.
  • The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was Q3 2021, with growth of 26.7%; the weakest was Q4 2023, with a decline of 53.2%.
  • According to Business Quant data, Property, Plant & Equipment (Net) for the three prior quarters was $199.4 million (Q1 2026), $205.4 million (Q4 2025) and $209.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.10 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 5.80 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 13.62 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 5.83 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 19.03 Bn
10 Emergent BioSolutions 321.73 Mn -429.17 Mn 137.20 Mn 178.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 178.00 Mn
Mar 31, 2026 199.40 Mn
Dec 31, 2025 205.40 Mn
Sep 30, 2025 209.80 Mn
Jun 30, 2025 216.10 Mn
Mar 31, 2025 221.00 Mn
Dec 31, 2024 270.60 Mn
Sep 30, 2024 278.10 Mn
Jun 30, 2024 306.20 Mn
Mar 31, 2024 379.40 Mn
Dec 31, 2023 382.80 Mn
Sep 30, 2023 395.40 Mn
Jun 30, 2023 395.50 Mn
Mar 31, 2023 716.80 Mn
Dec 31, 2022 817.60 Mn
Sep 30, 2022 806.80 Mn
Jun 30, 2022 798.40 Mn
Mar 31, 2022 807.50 Mn
Dec 31, 2021 800.10 Mn
Sep 30, 2021 768.70 Mn
API Access

Emergent BioSolutions Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=EBS&period=max&api_key=YOUR_API_KEY